Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physiological Impacts of Type 1 Diabetes on Exercise Performance: A Systematic Review and Narrative Synthesis of the Literature.

Canadian journal of diabetes·2026
Same author

Real-world performance of point-of-care metre, blood gas and laboratory glucose methods in Australian and American hospital inpatient cohorts.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Glucose Metrics During School Hours in Primary School-Aged Children With Type 1 Diabetes: A Population-Based Cohort Study.

Journal of paediatrics and child health·2026
Same author

Primary Care Physicians' Interactions With a Novel Web-Based Active Learning Tool (The Community Fracture Capture Learning Hub): Qualitative Analysis.

JMIR formative research·2026
Same author

Reduced Prevalence of Impaired Awareness of Hypoglycemia Over Two Decades in Population-Based Samples of Youth With Type 1 Diabetes.

Diabetes care·2026
Same author

Health Service Leaders' Perspectives on Type 1 Diabetes Models of Care for Children and Young Adults in Australia: A Mixed-Methods Study.

Journal of diabetes research·2026

Related Experiment Video

Updated: Jul 5, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

Islet Autoantibody Screening Throughout Australia Using In-Home Blood Spot Sampling: 2-Year Outcomes of Type1Screen.

John M Wentworth1,2,3,4, Anna B E Sing2,3, Gaetano Naselli3

  • 1Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Diabetes Care
|January 29, 2025
PubMed
Summary
This summary is machine-generated.

Type1Screen

More Related Videos

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Related Experiment Videos

Last Updated: Jul 5, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Area of Science:

  • Endocrinology
  • Immunology
  • Public Health

Background:

  • Type 1 diabetes (T1D) screening aims to prevent diabetic ketoacidosis (DKA) and enable early intervention.
  • Type1Screen provides islet autoantibody testing for Australians with a family history of T1D.
  • In-home capillary blood spot sampling was implemented to improve screening accessibility.

Purpose of the Study:

  • To evaluate the screening and monitoring outcomes of Type1Screen's in-home capillary blood spot sampling.
  • To compare blood spot screening with traditional venipuncture methods.
  • To assess the feasibility and effectiveness of widespread T1D screening.

Main Methods:

  • Analysis of data from 2,064 participants registered between July 2022 and June 2024.
  • Comparison of baseline characteristics and outcomes for 1,243 participants (967 blood spot, 276 venipuncture) tested by June 2024.
  • Evaluation of sample collection success rates, participant demographics, and autoantibody prevalence.

Main Results:

  • In-home blood spot screening was feasible, with lower sample collection failure rates than venipuncture.
  • Blood spot screening participants were younger and more likely to reside in regional Australia.
  • Preclinical type 1 diabetes prevalence was consistent with expectations for both methods, with no DKA cases reported in participants who screened positive.

Conclusions:

  • Type1Screen demonstrates national reach and feasibility of in-home blood spot screening for preclinical T1D.
  • Blood spot screening is particularly beneficial for younger individuals and those in regional areas.
  • The cost-effectiveness, convenience, and accessibility of blood spot screening can enhance early T1D diagnosis and management.